Browse by Basel Contributors ID
2016Kastien-Hilka, Tanja and Rosenkranz, Bernd and Bennett, Bryan and Sinanovic, Edina and Schwenkglenks, Matthias. (2016) How to evaluate health-related quality of life and its association with medication adherence in pulmonary tuberculosis - designing a prospective observational study in South Africa. Frontiers in pharmacology, 6. p. 125. 2014Schwenkglenks, Matthias and Gerbershagen, Hans J. and Taylor, Rod S. and Pogatzki-Zahn, Esther and Komann, Marcus and Rothaug, Judith and Volk, Thomas and Yahiaoui-Doktor, Maryam and Zaslansky, Ruth and Brill, Silviu and Ullrich, Kristin and Gordon, Debra B. and Meissner, Winfried. (2014) Correlates of satisfaction with pain treatment in the acute postoperative period : Results from the international PAIN OUT registry. Pain, Vol. 155, H. 7. pp. 1401-1411. Matter-Walstra, K. and Klingbiel, D. and Szucs, T. and Pestalozzi, B. C. and Schwenkglenks, M.. (2014) Using the EuroQol EQ-5D in Swiss Cancer Patients, Which Value Set Should be Applied? PharmacoEconomics, Vol. 32, no. 6. pp. 591-599. Jakovljevic, Mihajlo and Gutzwiller, Florian S. and Schwenkglenks, Matthias and Milovanovic, Olivera and Rancic, Nemanja and Varjacic, Mirjana and Stojadinovic, Dobrivoje and Dagovic, Aleksandar and Matter-Walstra, Klazien. (2014) Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma. JBUON, 19 (3). pp. 1111-1120. 2013Gutzwiller, Florian S. and Pfeil, Alena M. and Comin-Colet, Josep and Ponikowski, Piotr and Filippatos, Gerasimos and Mori, Claudio and Braunhofer, Peter G. and Szucs, Thomas D. and Schwenkglenks, Matthias and Anker, Stefan D.. (2013) Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose : FAIR-HF sub-analysis. International journal of cardiology, Vol. 168, H. 4. pp. 3878-3883. Schwenkglenks, Matthias and Bendall, Kate Louise and Pfeil, Alena M. and Szabo, Zsolt and Pettengell, Ruth. (2013) External validation of a risk model of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma. Leukemia & lymphoma, Vol. 54, H. 11. pp. 2426-2432. Rothaug, Judith and Zaslansky, Ruth and Schwenkglenks, Matthias and Komann, Marcus and Allvin, Renée and Backström, Ragnar and Brill, Silviu and Buchholz, Ingo and Engel, Christoph and Fletcher, Dominique and Fodor, Lucian and Funk, Peter and Gerbershagen, Hans J. and Gordon, Debra B. and Konrad, Christoph and Kopf, Andreas and Leykin, Yigal and Pogatzki-Zahn, Esther and Puig, Margarita and Rawal, Narinder and Taylor, Rod S. and Ullrich, Kristin and Volk, Thomas and Yahiaoui-Doktor, Maryam and Meissner, Winfried. (2013) Patients' perception of postoperative pain management : validation of the International Pain Outcomes (IPO) questionnaire. Journal of pain, Vol. 14, H. 11. pp. 1361-1370. Taylor, Rod S. and Ullrich, Kristin and Regan, Sophie and Broussard, Christina and Schwenkglenks, Matthias and Taylor, Rebecca J. and Gordon, Debra B. and Zaslansky, Ruth and Meissner, Winfried and Rothaug, Judith and Langford, Richard and Pain-OUT investigators, . (2013) The impact of early postoperative pain on health-related quality of life. Pain practice, Vol. 13, H. 7. pp. 515-523. 2012Matter-Walstra, Klazien and Joerger, Markus and Kühnel, Ursula and Szucs, Thomas and Pestalozzi, Bernhard and Schwenkglenks, Matthias. (2012) Cost-effectiveness of maintenance pemetrexed in patients with advanced nonsquamous-cell lung cancer from the perspective of the swiss health care system. Value in health, Vol. 15, H. 1. pp. 65-71. Pettengell, Ruth and Johnson, Hans E. and Lugtenburg, Pieternella J. and Silvestre, Antonio Salar and Dührsen, Ulrich and Rossi, Francesca G. and Schwenkglenks, Matthias and Bendall, Kate and Szabo, Zsolt and Jaeger, Ulrich. (2012) Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, Vol. 20, H. 3. pp. 647-652. Gutzwiller, Florian S. and Biller-Andorno, Nikola and Harnacke, Caroline and Bollhalder, Lea and Szucs, Thomas D. and Gutzwiller, Felix and Schwenkglenks, Matthias. (2012) Methoden zur Bestimmung von Nutzen bzw. Wert medizinischer Leistungen und deren Anwendung in der Schweiz und ausgewählten europäischen Ländern. Bern. 2011Pettengell, Ruth and Schwenkglenks, Matthias. (2011) Incidence of neutropenia, chemotherapy delivery, and use of colony-stimulating factor in patients with non-Hodgkin lymphoma of different age groups. Leukemia [and] lymphoma, Vol. 52, H. 6. pp. 1133-1136. Blank, Patricia R. and Moch, Holger and Szucs, Thomas D. and Schwenkglenks, Matthias. (2011) KRAS and BRAF mutation analysis in metastatic colorectal cancer : a cost-effectiveness analysis from a Swiss perspective. Clinical cancer research, Vol. 17, no. 19. pp. 6338-6346. Szucs, T. D. and Blank, P. R. and Schwenkglenks, M. and Aapro, M.. (2011) Potential health economic impact of intravenous iron supplementation to erythropoiesis-stimulating agent treatment in patients with cancer- or chemotherapy-induced anemia. Oncology, 81 (1). pp. 45-49. Schwenkglenks, Matthias and Brazier, John E. and Szucs, Thomas D. and Fox, Keith A. A.. (2011) Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of non-ST-segment elevation acute coronary syndromes. Value in health, Vol. 14, H. 1. pp. 24-33. Schwenkglenks, Matthias and Pettengell, Ruth and Jackisch, Christian and Paridaens, Robert and Constenla, Manuel and Bosly, André and Szucs, Thomas D. and Leonard, Robert. (2011) Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients : data from the INC-EU Prospective Observational European Neutropenia Study. Supportive care in cancer, Vol. 19, H. 4. pp. 483-490. Loibl, Sibylle and Skacel, Tomas and Nekljudova, Valentina and Lück, Hans Joachim and Schwenkglenks, Matthias and Brodowicz, Thomas and Zielinski, Christoph and von Minckwitz, Gunter. (2011) Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis. BMC cancer, Vol. 11. p. 131. Haioun, Corinne and Salar, Antonio and Pettengell, Ruth and Johnsen, Hans Erik and Duehrsen, Ulrich and Rossi, Francesca Gaia and Verhoef, Gregor and Schwenkglenks, Matthias and Jaeger, Ulrich and Hamilton, Lisa and Pujol, Beatriz and Lugtenburg, Pieternella Johanna. (2011) Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone ± rituximab chemotherapy : results from an observational study. Leukemia & lymphoma, Vol. 52, H. 5. pp. 796-803. Pettengell, R. and Schwenkglenks, M. and Bacon, P. and Lawrinson, S. and Duehrsen, U.. (2011) Pegfilgrastim primary prophylaxis in patients with non-Hodgkin lymphoma : results from an integrated analysis. Hematological oncology, Vol. 29, H. 4. pp. 177-184. Tomonaga, Yuki and Gutzwiller, Felix and Lüscher, Thomas F. and Riesen, Walter F. and Hug, Markus and Diemand, Albert and Schwenkglenks, Matthias and Szucs, Thomas D.. (2011) Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care : a cluster-randomised controlled trial. BMC family practice, Vol. 12. p. 12. Egevad, Lars and Algaba, Ferran and Berney, Daniel M. and Boccon-Gibod, Liliane and Compérat, Eva and Evans, Andrew J. and Grobholz, Rainer and Kristiansen, Glen and Langner, Cord and Lockwood, Gina and Lopez-Beltran, Antonio and Montironi, Rodolfo and Oliveira, Pedro and Schwenkglenks, Matthias and Vainer, Ben and Varma, Murali and Verger, Vincent and Camparo, Philippe. (2011) Interactive digital slides with heat maps : a novel method to improve the reproducibility of Gleason grading. Virchows Archiv, Vol. 459, H. 2. pp. 175-182. 2010Blank, Patricia R. and Schwenkglenks, Matthias and Moch, Holger and Szucs, Thomas D.. (2010) Human epidermal growth factor receptor 2 expression in early breast cancer patients : a Swiss cost-effectiveness analysis of different predictive assay strategies. Breast cancer research and treatment, Vol. 124, H. 2. pp. 497-507. Schwenkglenks, Matthias and Pettengell, Ruth and Szucs, Thomas D. and Culakova, Eva and Lyman, Gary H.. (2010) Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery. Journal of hematology & oncology, Vol. 3. p. 27. Romanens, Michel and Ackermann, Franz and Spence, John David and Darioli, Roger and Rodondi, Nicolas and Corti, Roberto and Noll, Georg and Schwenkglenks, Matthias and Pencina, Michael. (2010) Improvement of cardiovascular risk prediction : time to review current knowledge, debates, and fundamentals on how to assess test characteristics. European Journal of Cardiovascular Prevention and Rehabilitation, 17 (1). pp. 18-23. Aapro, Matti and Schwenkglenks, Matthias and Lyman, Gary H. and Lopez Pousa, Antonio and Lawrinson, Susan and Skacel, Tomas and Bacon, Pamela and von Minckwitz, Gunter. (2010) Pegfilgrastim primary prophylaxis vs. current practice neutropenia management in elderly breast cancer patients receiving chemotherapy. Critical reviews in oncology, hematology, Vol. 74, H. 3. pp. 203-210. 2009Blank, Patricia R. and Schwenkglenks, Matthias and Szucs, Thomas D.. (2009) Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. The journal of infection, Vol. 58. pp. 446-458. Blank, P. R. and Schwenkglenks, M. and Szucs, T. D.. (2009) Disparities in influenza vaccination coverage rates by target group in five European countries : trends over seven consecutive seasons. Infection, 37. pp. 390-400. Pettengell, Ruth and Bosly, André and Szucs, Thomas D. and Jackisch, Christian and Leonard, Robert and Paridaens, Robert and Constenla, Manuel and Schwenkglenks, Matthias and Impact of Neutropenia in Chemotherapy-European Study Group, . (2009) Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma : data from the INC-EU Prospective Observational European Neutropenia Study. British journal of haematology : the official journal of the British Society for Haematology and the European Haematology Association, Vol. 144. pp. 677-685. Romanens, Michel and Ackermann, Franz and Abay, Michael and Szucs, Thomas and Schwenkglenks, Matthias. (2009) Agreement of Swiss-adapted international and European guidelines for the assessment of global vascular risk and for lipid lowering interventions. Cardiovascular drugs and therapy, Vol. 23. pp. 249-254. Dedes, Konstantin J. and Matter-Walstra, Klazien and Schwenkglenks, Matthias and Pestalozzi, Bernhard C. and Fink, Daniel and Brauchli, Peter and Szucs, Thomas D.. (2009) Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer : an economic evaluation. EJC : European journal of cancer, Vol. 45, H. 8. pp. 1397-1406. McCann, S. and Schwenkglenks, M. and Bacon, P. and Einsele, H. and D'Addio, A. and Maertens, J. and Niederwieser, D. and Rabitsch, W. and Roosaar, A. and Ruutu, T. and Schouten, H. and Stone, R. and Vorkurka, S. and Quinn, B. and Blijlevens, N. and Ebmt Mucositis Advisory Group, . (2009) The Prospective Oral Mucositis Audit : relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT. Bone marrow transplantation, Vol. 43. pp. 141-147. von Minckwitz, G. and Schwenkglenks, M. and Skacel, T. and Lyman, G. H. and Pousa, A. Lopez and Bacon, P. and Easton, V. and Aapro, M. S.. (2009) Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management : results from an integrated analysis. European journal of cancer, Vol. 45, H. 4. pp. 608-617. 2008Blijlevens, Nicole and Schwenkglenks, Matthias and Bacon, Pamela and D'Addio, Alessandra and Einsele, Hermann and Maertens, Johan and Niederwieser, Dietger and Rabitsch, Werner and Roosaar, Ann and Ruutu, Tapani and Schouten, Harry and Stone, Rebecca and Vokurka, Samuel and Quinn, Barry and McCann, Shaun and European Blood, and Marrow Transplantation Mucositis Advisory Group, . (2008) Prospective oral mucositis audit : oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy : european blood and marrow transplantation mucositis advisory group. Journal of clinical oncology, Vol. 26. pp. 1519-1525. Pettengell, Ruth and Schwenkglenks, Matthias and Leonard, Robert and Bosly, André and Paridaens, Robert and Constenla, Manuel and Szucs, Thomas D. and Jackisch, Christian and Impact of Neutropenia in Chemotherapy-European Study Group, . (2008) Neutropenia occurrence and predictors of reduced chemotherapy delivery : results from the INC-EU prospective observational European neutropenia study. Supportive care in cancer, Vol. 16, H. 11. pp. 1299-1309. Blank, Patricia R. and Schwenkglenks, Matthias and Szucs, Thomas D.. (2008) Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC Public Health, Vol. 8. p. 272. Blank, Patricia R. and Freiburghaus, Andreas U. and Ruf, Bernhard R. and Schwenkglenks, Matthias M. and Szucs, Thomas D.. (2008) Trends in influenza vaccination coverage rates in Germany over six seasons from 2001/02 to 2006/07. Medizinische Klinik, 103 (11). pp. 761-768. Blank, Patricia R. and Freiburghaus, Andreas U. and Schwenkglenks, Matthias M. and Szucs, Thomas D. and Kunze, Ursula. (2008) Influenza vaccination coverage rates in Austria in 2006/07 - a representative cross-sectional telephone survey. Wiener medizinische Wochenschrift, Vol. 158, H. 19-20. pp. 583-588. Pettengell, R. and Schwenkglenks, M. and Bosly, A.. (2008) Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy. Annals of hematology, Vol. 87, issue 5. pp. 429-430. |
